A detailed history of Gamma Investing LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 535 shares of BIO stock, worth $178,106. This represents 0.02% of its overall portfolio holdings.

Number of Shares
535
Previous 321 66.67%
Holding current value
$178,106
Previous $87.7 Million 104.18%
% of portfolio
0.02%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$263.97 - $344.64 $56,489 - $73,752
214 Added 66.67%
535 $179 Million
Q2 2024

Jul 02, 2024

BUY
$268.26 - $339.48 $23,338 - $29,534
87 Added 37.18%
321 $87.7 Million
Q1 2024

Apr 05, 2024

BUY
$304.11 - $351.99 $31,627 - $36,606
104 Added 80.0%
234 $80.9 Million
Q4 2023

Feb 01, 2024

BUY
$269.37 - $365.04 $35,018 - $47,455
130 New
130 $41.8 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.2B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.